Trescal announces the acquisition of RS Calibration, an A2LA accredited calibration, qualification and validation laboratory dedicated primarily to the life sciences sector.
Established in 1995 and located in Pleasanton (northeast of San Francisco), RS Calibration employs 41 people and offers on-site and laboratory calibration and validation services, particularly to pharmaceutical, biotechnology and medical device manufacturers. The company, which specializes in FDA and cGMP environmental requirements, generated sales of $5.5 million in 2017.
Its founder and ceo, Ralph Sabiel, will remain in office to continue the development of this entity within the Trescal Group.
Guillaume Caroit, Managing Director Trescal: "This acquisition is very important for Trescal's development in the U.S. market, as it expands our geographic coverage in California and strengthens our service offering for the life sciences sector, one of the most dynamic in the United States."
This is the first acquisition since the acquisition of Trescal by Omers, the main shareholder